Ronald G. Gelbman, Director at HAEMONETICS CORP (HAE), sold 6,000 shares at $71.90 ($431K) on 2012-08-23, disclosed to the SEC on 2012-08-27.
Seasonal sale ($431k) by Director — this insider has traded HAE in August in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| HAE | SELL | 2019-02-19 | $1.4M | — | Filing → |
| HAE | SELL | 2018-12-18 | $892K | — | Filing → |
| HAE | SELL | 2017-11-17 | $331K | — | Filing → |